| Imagion Biosystems Limited (IBX) ORDINARY FULLY PAID |
Health Care |
$6 |
Cleansing Statement - Section 708A(12C)(e)
|
23 Apr 2026 2:14PM |
$0.021 |
$0.012 |
fallen by
41.46%
|
|
| Earlypay Ltd (EPY) ORDINARY FULLY PAID |
Financials |
$31 |
Resignation of Non-Executive Director
|
23 Apr 2026 2:10PM |
$0.150 |
$0.125 |
fallen by
16.67%
|
|
| Zip Co Limited (ZIP) ORDINARY FULLY PAID |
Financials |
$3,675 |
Change in substantial holding
|
23 Apr 2026 2:05PM |
$2.495 |
$2.930 |
risen by
17.43%
|
|
| Select Harvests Limited (SHV) ORDINARY FULLY PAID |
Consumer Staple |
$539 |
Ceasing to be a substantial holder
|
23 Apr 2026 2:02PM |
$3.830 |
$3.810 |
fallen by
0.52%
|
|
| Elsight Limited (ELS) ORDINARY FULLY PAID |
Information Technology |
$1,575 |
Becoming a substantial holder
|
23 Apr 2026 1:59PM |
$6.670 |
$7.100 |
risen by
6.45%
|
|
| Collins Foods Limited (CKF) ORDINARY FULLY PAID |
Consumer Discretionary |
$977 |
Ceasing to be a substantial holder
|
23 Apr 2026 1:56PM |
$8.340 |
$8.270 |
fallen by
0.84%
|
|
| Australian Strategic Materials Limited (ASM) ORDINARY FULLY PAID |
Materials |
$329 |
FIRB approval received for Energy Fuels' acquisition of ASM
|
23 Apr 2026 1:55PM |
$1.675 |
$1.210 |
fallen by
27.76%
|
|
ASM - Price-sensitive ASX Announcement
Full Release
Key Points
- FIRB approval received for Energy Fuels' acquisition of ASM.
- Acquisition involves separate schemes for shares and options.
- Approval under the Foreign Acquisitions and Takeovers Act 1975.
- ASM Directors recommend voting in favor of the acquisition schemes.
- Schemes expected to be implemented by early July 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Triangle Energy (Global) Limited (TEG) ORDINARY FULLY PAID |
Energy |
$2 |
Shareholders Reminded to Lodge their TFN with Automic
|
23 Apr 2026 1:54PM |
$0.003 |
$0.001 |
fallen by
66.67%
|
|
| Tasman Resources Limited (TAS) ORDINARY FULLY PAID |
Materials |
$29 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
23 Apr 2026 1:48PM |
$0.051 |
$0.052 |
risen by
1.96%
|
|
TAS - Price-sensitive ASX Announcement
Full Release
Key Points
- Tasman Resources Ltd holds $15.5 million in cash and cash equivalents.
- Planning for a maiden drill hole at Titan West in partnership with Fortescue.
- Historic drilling at Parkinson Dam confirmed high-grade gold-silver mineralisation.
- Tasman Resources holds a 13.3% share in Eden Innovations Ltd valued at $14.2 million.
- Net cash used in operating activities for the quarter was $109,000.
- Net cash used in investing activities for the quarter was nil with previous year-to-date spending at $356,000.
- Net cash from financing activities for the quarter resulted in a deficit of $58,000.
- The cash balance at the end of the quarter was $1.294 million.
- Payments to related parties totaled $23,000 for director fees.
- Tasman Resources is actively reviewing new exploration acquisition opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PWR Holdings Limited (PWH) ORDINARY FULLY PAID |
Consumer Discretionary |
$807 |
Initial Director's Interest Notice - Susan Forrester
|
23 Apr 2026 1:42PM |
$9.250 |
$8.020 |
fallen by
13.30%
|
|
| Australian Clinical Labs Limited (ACL) ORDINARY FULLY PAID |
Health Care |
$414 |
Notification of cessation of securities - ACL
|
23 Apr 2026 1:41PM |
$1.950 |
$2.220 |
risen by
13.85%
|
|
| Pacific Resources Limited (PXR) ORDINARY FULLY PAID |
Energy |
$4 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
23 Apr 2026 1:39PM |
$0.001 |
$0.001 |
fallen by
0%
|
|
PXR - Price-sensitive ASX Announcement
Full Release
Key Points
- Pacific Resources Limited (PXR) provided an update on its activities for the quarter ended 31 March 2026.
- The company is focused on exploration and development of mineral resources, including the Sulphide Creek Gold-Antimony Project and Mersey VMS Base Metals and Gold Project in Tasmania.
- PXR holds an exclusive option to acquire gold, silver, base metals, and critical minerals assets, and has an investment interest in an ASX-listed copper exploration company.
- For the quarter, PXR reported net cash used in operating activities of $139,000 and $70,000 in investing activities.
- The net cash from financing activities was a decrease of $2,000.
- Cash and cash equivalents at the end of the quarter were $970,000.
- Corporate changes included board resignations and appointments, with Ian Neilson joining as an Independent Non-Executive Director.
- PXR continued planning for fieldwork at the Mersey Project and completed a channel sampling program at Sulphide Creek's Coupon Prospect.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Waratah Minerals Limited (WTM) ORDINARY FULLY PAID |
Materials |
$198 |
Notice of Annual General Meeting/Proxy Form
|
23 Apr 2026 1:30PM |
$0.715 |
$0.510 |
fallen by
28.67%
|
|
| Tartana Minerals Limited (TAT) ORDINARY FULLY PAID |
Materials |
$8 |
Corporate Presentation - The Hole Story
|
23 Apr 2026 1:29PM |
$0.026 |
$0.020 |
fallen by
23.08%
|
|
TAT - Price-sensitive ASX Announcement
Full Release
Key Points
- Tartana Minerals Limited undertook a $4.5 million capital raising led by Alpine Capital.
- The company focuses on copper sulphate pentahydrate production and aims to increase copper resources.
- Key projects include Mountain Maid and Cardross with significant gold resources.
- Zinc resources total 39,000 tonnes and are open at depth on a mining lease.
- Exploration targets include silver-lead-antimony at the Nightflower Project.
- Tartana Minerals holds extensive tenement positions in Far North Queensland.
- The company plans to refurbish the heap leach and solvent extraction plant to optimize production.
- Copper production is linked to the LME copper price plus a premium.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Challenger Limited (CGF) ORDINARY FULLY PAID |
Financials |
$6,715 |
Ceasing to be a substantial holder for ENN
|
23 Apr 2026 1:28PM |
$8.285 |
$9.820 |
risen by
18.53%
|
|
| Elanor Investor Group (ENN) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Consumer Discretionary |
$8 |
Ceasing to be a substantial holder from CGF
|
23 Apr 2026 1:28PM |
$0.820 |
$0.060 |
fallen by
92.68%
|
|
| Gowing Brothers Ltd (GOW) ORDINARY FULLY PAID |
Financials |
$120 |
Application for quotation of securities - GOW
|
23 Apr 2026 1:27PM |
$2.270 |
$2.220 |
fallen by
2.20%
|
|
| Taiton Resources Limited (T88) ORDINARY FULLY PAID |
Materials |
$5 |
Update - Proposed issue of securities - T88
|
23 Apr 2026 1:16PM |
$0.075 |
$0.040 |
fallen by
46.67%
|
|
| Southern Hemisphere Mining Limited (SUH) ORDINARY FULLY PAID |
Materials |
$18 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
23 Apr 2026 1:11PM |
$0.025 |
$0.025 |
fallen by
0%
|
|
SUH - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of Phase I deep-drilling program at Southern Porphyry target.
- Significant mineralization results indicating proximity to a porphyry core.
- Phase II drilling to target the high-grade porphyry core.
- Net cash outflow from operating activities of $473,000 for the quarter.
- JV partner FMR Resources Limited contributed $999,000 towards drilling expenses.
- End of quarter cash balance of $999,000 with a $0.5 million drawdown facility.
- Outlook includes further drilling and assay activities in the next quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pinnacle Minerals Limited (PIM) ORDINARY FULLY PAID |
Materials |
$4 |
Quarterly Activity and Cashflow Report
|
23 Apr 2026 1:07PM |
$0.042 |
$0.033 |
fallen by
21.43%
|
|
PIM - Price-sensitive ASX Announcement
Full Release
Key Points
- Pinnacle streamlined its portfolio, terminating U.S. projects without financial impact.
- Retained core projects in Australia and Canada in good standing.
- Appointment of Ari Zaetz as Non-Executive Director strengthened the board.
- Quarter ended with cash and cash equivalents of approximately A$2.56 million.
- Strategic review to unlock value across retained assets is ongoing.
- Focus on new opportunities in critical minerals, precious metals, and battery minerals.
- Emphasis on disciplined capital management and strategic partnerships.
- No on-ground exploration at Adina East during the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cambium Bio Limited (CMB) ORDINARY FULLY PAID |
Health Care |
$12 |
FDA Confirms Single Pivotal Trial Pathway for Elate Ocular
|
23 Apr 2026 1:01PM |
$0.385 |
$0.445 |
risen by
15.58%
|
|
CMB - Price-sensitive ASX Announcement
Full Release
Key Points
- FDA confirms single-trial pathway for Elate Ocular®.
- Significant reduction in development cost and accelerated timeline.
- Increased probability of success with a single well-powered study.
- Phase 3 study design confirmed with 400 evaluable subjects.
- Fast Track Designation allows rolling BLA submission.
- Focus on initiating pivotal Phase 3 study with enrolment in 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Norwood Systems Limited (NOR) ORDINARY FULLY PAID |
Information Technology |
$18 |
Norwood secures additional working capital funding of $80k
|
23 Apr 2026 1:00PM |
$0.011 |
$0.031 |
risen by
181.82%
|
|
NOR - Price-sensitive ASX Announcement
Full Release
Key Points
- Norwood Systems Limited secured an additional $80,000 in working capital funding.
- The funding agreement is with Plough Lane Superannuation Pty Ltd.
- The interest rate on the loan is 9.75%.
- Repayment is due by 30 June 2026.
- An establishment fee of 4% plus GST is applicable.
- The loan is unsecured.
- Dr John Tarrant is a key figure associated with the lender.
- Paul Ostergaard, Managing Director, thanked Dr Tarrant for the support.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ADX Energy Ltd (ADX) ORDINARY FULLY PAID |
Energy |
$23 |
ADX Webinar Presentation
|
23 Apr 2026 12:54PM |
$0.030 |
$0.026 |
fallen by
13.33%
|
|
| Taiton Resources Limited (T88) ORDINARY FULLY PAID |
Materials |
$5 |
Update - Proposed issue of securities - T88
|
23 Apr 2026 12:51PM |
$0.079 |
$0.040 |
fallen by
49.37%
|
|
| N1 Holdings Limited (N1H) ORDINARY FULLY PAID |
Financials |
$8 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
23 Apr 2026 12:48PM |
$0.100 |
$0.092 |
fallen by
8%
|
|
N1H - Price-sensitive ASX Announcement
Full Release
Key Points
- Record settlement volumes achieved in the March 2026 quarter, driving strong performance across revenue, net profit, and cash receipts.
- The company maintained a consistent origination strategy despite challenging market conditions marked by interest rate increases and geopolitical uncertainty.
- Net profit for FYTD before income tax was approximately $1,351,000 (unaudited) with EBITDA of $1,582,000 (unaudited).
- Revenue for FYTD was $15.96 million (unaudited), an 8.87% increase from the previous year.
- Significant contributions from the SME lending business, which accounted for 95% of total cash receipts.
- Net cash outflow from operating activities for Q3 FY26 was $25.95 million, adjusted to an inflow of $1.98 million excluding commercial lending activities.
- Cash balance at the end of the quarter was $8.89 million.
- Operational costs remained stable, supported by AI initiatives improving efficiency and scalability.
- The company is positioned as a property-backed private credit lender in the Australian SMEs sector, with unique competitive advantages.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
